Lonza and ABL Bio collaborate on development and manufacture of new bispecific antibody product
Lonza supports development and manufacturing of ABL Bio’s bispecific antibody candidate with a complete and integrated end-to-end solution
Lonza supports development and manufacturing of ABL Bio’s bispecific antibody candidate with a complete and integrated end-to-end solution
Abbas will closely partner with CBC's business teams to identify, assess, and pursue investment opportunities and strategic acquisitions
The upcoming portfolio of respiratory products aims to provide effective solutions for a range of respiratory conditions
Brimonidine Tartrate Ophthalmic Solution is an alpha adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure
The facility is over 79,000 square feet and is equipped with packaging lines
The event witnessed a historic journey of Thalassemics India gracing the theme “LAKSH”
Department of Biotechnology is going to play an important part in the integrated holistic healthcare approach against elimination of Tuberculosis
The company is addressing these observations
India has a pivotal role in eliminating TB
Integration of modern and traditional medicine to facilitate the illness to wellness journey
Subscribe To Our Newsletter & Stay Updated